ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    ABH Subtype-Specific Tolerance after ABO-Mismatched Hematopoietic Cell Transplantation

    B. Motyka1, A. Halpin1, J. Pearcey1, A. Kariminia2, A. Halevy2, S. Maier1, A. Halevy2, P. Subrt2, C. W. Cairo1, G. D. Cuvelier3, K. R. Schultz2, L. J. West1

    1Alberta Transplant Institute, University of Alberta, Edmonton, AB, Canada, 2British Columbia Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada, 3CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada

    *Purpose: ABO-mediated immunity is reported to have minimal detrimental impact after ABO-mismatched hematopoietic cell transplantation (HCT). Patients are generally presumed ‘tolerant’ with regard to ABO.…
  • 2020 American Transplant Congress

    Incidence of Non-Tuberculous Mycobacteria in the Transplant Population at a University Transplant Center in Northern Florida

    D. Schain, Z. Breslow, G. El Helou, A. Cannella

    Medicine/IDGM, Univ of Florida, College of Med, Gainesville, FL

    *Purpose: Over the past decade, there has been an increase in the number of non-tuberculous mycobacteria (NTM) infections in the United States, especially in the…
  • 2020 American Transplant Congress

    Impact of Kidney Allocation System on Waiting List Outcomes for Candidates Listed in Veterans Affairs Programs

    J. Walker1, B. Concepion2, K. Birdwell2, I. Feurer3, S. Rega4, D. Shaffer5, R. Forbes5

    1Surgery, Vanderbilt University Medical Center (VUMC), Nashville, TN, 2Nephrology, VUMC, Nashville, TN, 3Surgery and Biostatistics, VUMC, Nashville, TN, 4Transplant Center, VUMC, Nashville, TN, 5Surgery, Division of Kidney and Pancreas Transplantation, VUMC, Nashville, TN

    *Purpose: Kidney Allocation System (KAS) changes in 2014 prioritized highly sensitized candidates and aimed to improve longevity matching. Given that veterans are older and less…
  • 2020 American Transplant Congress

    Predicting Kidney Discard among Donors Age 0-3: A Discard Risk Index

    M. Joshi, M. Price, A. Rana

    Baylor College of Medicine, Houston, TX

    *Purpose: Among pediatric kidney donors the discard rate is highest among donors under 3-years-old. This study aims to identify factors predicting discard and construct a…
  • 2020 American Transplant Congress

    1 -Year Protocol Biopsies in Pediatric Kidney Transplant Children: Are Unfavorable Histological Lesions Related to No Adherence?

    M. L. Monteverde1, J. M. Velasco1, V. Solernou2, J. P. Ibanez1, C. Cernadas3, A. B. Chaparro4, Y. L. Marcos5

    1Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina, 2Pathology, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina, 3Teaching and Investigation, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina, 4Nephrology, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina, 5Hemoteraphy, Hospital de Pediatria JP Garrahan, Buenos Aires, Argentina

    *Purpose: In adults with kidney transplantation (KT), histological findings in surveillance biopsies at 1-year post KT are independent correlate to short and long-term graft survival.…
  • 2020 American Transplant Congress

    Tumor of Transplanted Kidney: Graft Resection Preserves Renal Function with Good Long-Term Oncologic Outcome

    J. Chlupac, T. Marada, M. Kudla, L. Janousek, J. Fronek

    Transplantation Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Incidence of urologic tumors is increased in renal transplant recipients. In case of a kidney transplant neoplasm, the graft-nephrectomy and hemodialysis reduce the quality…
  • 2020 American Transplant Congress

    Comparative Outcome Evaluation of Kidney Donors with and without Sickle Cell Trait

    A. Alshaqaq, N. Musaied, A. AlAbadi, M. AlBugami, F. AlOtaibi, K. Hamawi, K. Bel’eed-Akkari

    Multi-Organ Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia

    *Purpose: Kidney transplant programs in Saudi Arabia (KSA) are predominantly based on living kidney donation. Sickle cell trait (SCT) is prevalent in the Eastern and…
  • 2020 American Transplant Congress

    Clinical Study of Standard versus Reduced Dose Tacrolimus Combined with Generic Mycophenolate Mofetil in De Novo Kidney Transplantation

    J. Bang, C. Oh

    Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of

    *Purpose: The lowering of calcineurin inhibitor exposure is possibly considered as the proper strategy to prevent calcineurin inhibitor induced nephrotoxicity in kidney transplant. This clinical…
  • 2020 American Transplant Congress

    Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study

    J. Lee1, E. Kim1, S. Yang1, S. Kim1, J. Lee1, J. Park2, H. Choi3, B. Kim2, D. Joo1, S. Kim1, M. Kim1

    1Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, 2Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, 3Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of

    *Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…
  • 2020 American Transplant Congress

    Post Liver Transplant Biliary Complications in the Post HCV Era

    M. Birch, K. Halazun, D. Tsapepas, C. Brenna, B. Samstein

    New York Presbyterian - Weill Cornell Medical Center, New York, NY

    *Purpose: Biliary complications in the post HCV era has not been well defined.*Methods: We retrospective studied 209 patients transplanted from April 2015 to November 2019…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences